Skip to main content
Log in

Effects of Combination Therapy with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber and Oral Vancomycin on Fulminant Pseudomembranous Colitis with Septic Shock

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We report 2 cases of fulminant pseudomembranous colitis with septic shock. The first case showed few symptoms, whereas the second case showed recurrence. Both cases rapidly developed shock and blood pressure was uncontrollable except with the use of pressor agents. Direct hemoperfusion using polymyxin B-immobilized fiber, which was previously demonstrated to have excellent therapeutic effects for the treatment of hypotension in septic shock by removing circulating lipopolysaccharide and oral vancomycin dramatically improved both cases’ clinical status and decreased their APACHE II scores (from 18 to 8 and from 16 to 9 points, respectively). Therefore, we suggest that direct hemoperfusion using polymyxin B-immobilized fiber improved hypotension-correcting cytokine balance with adsorption of endogenous cannabinoids in serum. Although colectomy is often performed to treat fulminant pseudomembranous colitis with septic shock, direct hemoperfusion can be easily performed with little risk to the patient. These cases strongly indicated that our combination therapy provides an important treatment for fulminant pseudomembranous colitis with septic shock.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB (1978) Antibiotics-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med 298:531–534

    Article  PubMed  CAS  Google Scholar 

  2. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME (1997) Recurrent Clostridium difficile diarrhea. Characteristics of and risk factors for patients enrolled in prospective, randomized, double-blinded trial. Clin Infect Dis 24:324–333

    PubMed  CAS  Google Scholar 

  3. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829

    Article  PubMed  CAS  Google Scholar 

  4. Farrell RJ, LaMont JT (2000) Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immun 26:416–421

    Google Scholar 

  5. Klingler PJ, Metzger PP, Seelig MH, Pettit PD, Knudsen JM, Alvarez SA (2000) Clostridium difficile infection: risk factors, medical and surgical management. Dig Dis 18:147–160

    Article  PubMed  CAS  Google Scholar 

  6. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL (2002) Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235:363–372

    Article  PubMed  Google Scholar 

  7. Palmer JD, Rifkind D (1974) Neutralization of the hemodynamic effects of endotoxin by polymyxin B. Surg Gynecol Obstet 138:755–759

    PubMed  CAS  Google Scholar 

  8. Aoki H, Kodama M, Tani T, Hanasawa K (1994) Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 167:412–417

    Article  PubMed  CAS  Google Scholar 

  9. Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28:682–686

    PubMed  CAS  Google Scholar 

  10. Varga K, Wagner JA, Bridgen DT, Kunos G (1998) Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12:1035–1044

    PubMed  CAS  Google Scholar 

  11. Thomas JA (2000) Toll genes and responsiveness to bacterial endotoxin. N Engl J Med 342:664–665

    Article  PubMed  CAS  Google Scholar 

  12. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S (1999) Differential roles of TLR 2 and TLR 4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443–451

    Article  PubMed  CAS  Google Scholar 

  13. Klein TW, Lane B, Newton CA, Friedman H (2000) The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 225:1–8

    Article  PubMed  CAS  Google Scholar 

  14. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, Akashi M, Nakata M, Kitajima I, Maruyama I (2000) Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Letters 470:151–155

    Article  PubMed  CAS  Google Scholar 

  15. Hecht G, Pothoulakis C, LaMont JT, Madara JL (1998) Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 82:1516–1524

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihide Kimura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimura, Y., Sato, K., Tokuda, H. et al. Effects of Combination Therapy with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber and Oral Vancomycin on Fulminant Pseudomembranous Colitis with Septic Shock. Dig Dis Sci 52, 675–678 (2007). https://doi.org/10.1007/s10620-006-9494-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9494-5

Keywords

Navigation